Twist Biopharma, a division of Twist Bioscience, is revolutionizing antibody discovery and optimization through its innovative synthetic biology platform. When the company sought to showcase its cutting-edge technology and demonstrate its capabilities in antibody engineering, they turned to a custom antibody project. Leveraging their proprietary "Library of Libraries" and advanced screening methods, Twist Biopharma successfully engineered a high-affinity antibody against a challenging target protein. This project not only highlighted the power and versatility of Twist's platform but also showcased their ability to rapidly generate optimized antibodies for therapeutic applications. The resulting antibody exhibited exceptional specificity and potency, surpassing traditional discovery methods in both speed and performance. This case study serves as a testament to Twist Biopharma's expertise in accelerating the drug discovery process and their potential to transform the biopharmaceutical industry.
.png){kind=small}
